COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
CGM reports FY 2024 financials in line with revised guidance and expects to return to growth path in 2025
CGM reports FY 2024 financials in line with revised guidance, with recurring revenues accounting for 74% of total revenues. Company investing in AI and expects growth in 2025 -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Ad-hoc: CompuGroup Medical SE & Co. KGaA intends to reduce the annual dividend for the financial year 2024 to the legal minimum
CompuGroup Medical SE & Co. KGaA plans to reduce 2024 dividend to legal minimum of EUR 0.05 per share, citing long-term growth focus and financial performance -
-
-
